Sarepta Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -35.93M-29.70M-90.28M-133.79M-220.03M-267.26M-50.69M-361.92M-715.08M-554.37M-418.78M-704.10M-536.14M234.99M
Depreciation and Depletion 1.22M0.80M1.00M0.80M3.20M4.70M5.00M6.40M10.20M22.80M25.20M36.60M40.00M42.50M42.70M
Share-based Compensation 2.37M3.17M3.13M3.08M11.13M20.34M32.12M29.96M30.50M50.13M78.60M108.07M113.94M233.02M182.51M205.13M
Gains from Sales and Divestitures 0.00M0.01M0.03M0.02M0.06M0.08M0.19M0.10M0.16M0.28M0.39M0.64M0.73M
Gains from Investment Securities 0.98M2.42M2.52M4.19M5.22M6.52M5.44M8.81M8.39M8.35M7.84M8.20M9.13M9.58M8.88M
Asset Writedowns and Impairment 0.13M0.41M0.11M
Non-cash Items 0.74M36.25M1.05M7.79M2.62M38.66M3.29M551.13M587.19M2.02M248.48M4.69M5.95M6.27M
Cash from Operations -8.80M-15.21M-23.68M-29.69M-64.69M-128.54M-149.47M-245.82M-232.00M-388.66M-456.46M107.47M-443.17M-325.35M-500.99M-205.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 2.43M-0.65M-0.08M0.89M-0.10M-10.65M-46.18M-40.28M
Depreciation & Amortization (CF) 1.38M1.46M1.30M1.52M1.28M3.69M5.25M5.61M8.09M12.24M24.50M26.91M38.02M41.86M44.40M37.72M
Change in Working Capital
Change in Receivables -2.62M1.21M1.06M1.08M-1.18M-1.11M1.56M1.25M24.24M19.58M41.84M10.46M51.65M61.64M185.70M201.66M
Change in Inventory 12.81M70.79M41.84M45.93M60.58M83.77M50.78M147.71M395.17M
Change in Accured Expenses 0.31M0.86M8.00M-1.72M9.47M10.76M18.30M7.31M12.93M90.16M122.98M42.00M23.30M147.57M-50.13M110.65M
Other Working Capital Changes 2.51M-1.62M34.01M-15.25M9.01M15.35M136.64M102.09M749.43M-103.20M-89.24M-86.83M-32.16M
Investing Activities
Capital Expenditures 0.93M0.83M1.18M0.11M2.37M25.44M3.40M5.34M12.00M61.16M59.63M82.20M38.49M30.82M76.11M136.96M
Change in Intangibles 1.06M1.12M1.13M1.04M1.41M1.38M1.43M1.52M125.00M3.19M3.08M108.07M102.00M1.43M102.00M10.00M
Acquisitions 172.56M
Change in Acquisitions & Divestments 0.11M134.91M185.94M112.10M296.23M865.81M1715.63M1189.48M466.00M923.22M1868.48M2002.11M
Cash from Investing Activities -1.88M-1.96M-2.31M-1.15M-11.67M-159.03M8.41M-90.19M-178.81M-370.49M286.73M-121.72M495.41M-1046.88M-165.80M755.56M
Financing Activities
Other financing activities 2.17M0.23M0.03M0.40M2.17M15.15M9.06M9.13M6.33M1.43M0.72M
Cash from Financing Activities 47.77M2.48M32.30M178.60M145.67M104.16M147.81M378.13M888.08M530.15M642.55M682.32M561.57M232.51M125.00M124.81M
Additional items
Change in Cash 37.08M-14.69M6.32M147.76M69.30M-183.41M6.75M42.12M477.27M-229.00M472.82M668.07M613.81M-1139.72M-541.79M674.58M
Free Cash Flow -9.73M-16.04M-24.86M-29.80M-67.06M-153.98M-152.87M-251.16M-244.00M-449.82M-516.09M25.26M-481.66M-356.17M-577.10M-342.74M
Net Cash Flow 37.08M-14.69M6.32M147.76M69.30M-183.41M6.75M42.12M477.27M-229.00M472.82M668.07M613.81M-1139.72M-541.79M674.58M